Related Experiment Videos
Management of Crohn's disease--a practical approach
Doug Knutson1, Greg Greenberg, Holly Cronau
1Department of Family Medicine, Ohio State University College of Medicine and Public Health, Columbus, Ohio 43201, USA.
American Family Physician
|September 4, 2003
Summary
Crohn's disease is a chronic gastrointestinal inflammatory disorder. Treatment varies by severity, from salicylates and antibiotics for mild cases to steroids and immunosuppressants for severe or refractory disease.
Area of Science:
- Gastroenterology
- Immunology
Background:
- Crohn's disease is a chronic gastrointestinal inflammatory disorder affecting up to 480,000 individuals in the U.S.
- Symptoms include abdominal pain, diarrhea, fever, malaise, and arthralgias, leading to significant morbidity.
- Etiologies are speculated to be genetic, environmental, dietary, infectious, and immunologic.
Purpose of the Study:
- To outline current treatment modalities for Crohn's disease based on disease severity.
- To discuss the efficacy of various therapeutic agents, including biologics.
Main Methods:
- Review of existing literature on Crohn's disease treatment guidelines.
- Analysis of therapeutic approaches ranging from conventional medications to advanced biologic therapies.
Main Results:
- Mild to moderate Crohn's disease may be managed with salicylates and/or antibiotics.
- Severe active disease typically requires steroids, with immunosuppressants used as adjunctive therapy.
- Infliximab, an anti-tumor necrosis factor alpha antibody, shows success in severe refractory cases with mild side effects.
Conclusions:
- Treatment strategies for Crohn's disease are stratified according to disease severity.
- Management of comorbid conditions is crucial for improving patient quality of life.
- Advanced therapies like infliximab offer effective options for refractory disease.